Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin and celecoxib for postoperative pain after tibia fracture surgery
IRCT20191104045328N52Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin and celecoxib in postoperative pain (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Pain score, Duration of anesthesia and 4 more. Started May 2026; status: completed.
02
Drugs
gabapentincelecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20191104045328N52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N52.